| |
| Magyar Ortopéd Társaság |
|
| 16. Európai Szövetbankkongresszus - 16th International Congress of the European Association of Tissue Banks |
 Rendezvény kezdete: 2007.10.17. | Rendezvény vége: 2007.10.20. |
| Szervező: Congress Secretariat |
| Munkahely neve: Asszisztencia Szervező Kft. |
| Címe: 1136 Budapest, Hegedus Gy. u. 20. |
| Tel: +36 1 350 1854 |
| Fax: +36 1 350 0929 |
| E-mail: eatb@asszisztencia.hu |
| Helyszín: 1113 Budapest, DANUBIUS HOTEL FLAMENCO****, Tas vezér u. 3-7. |
| A rendezvény Web oldala: http://www.asszisztencia.hu/eatb |
Important Dates:
May 18, 2007:
2nd Announcement and call for abstracts
August 31, 2007:
Deadline for abstract submission
September 15, 2007:
Deadline for abstract evaluation
August 31, 2007:
Deadline for early registration
September 17, 2007:
Deadline for hotel reservation and payment
October 15, 2007:
Deadline for standard registration
|
|
|
 |
| |
| Magyar Endokrinológiai és Anyagcsere Társaság |
|
| XIV CAPRI CONFERENCE "Novel Mechanisms and clinical aspects of cardiovascular disorders |
| Rendezvény kezdete: 2011.04.15. | Rendezvény vége: 2011.04.17. |
| Szakterület(ek): Hipertónia, Kardiológia |
| Tudományos információ: Aristea International |
| Címe: Italy, 00198 Roma, Via Lima, 31 |
| Tel: +39 06 845431 |
| Fax: +39 06 84543700 |
| E-mail: roma@aristea.com |
| Szervező: Aristea International |
| Munkahely neve: Aristea |
| Címe: Italy, 00198 Roma, Via Lima, 31 |
| Tel: +39 06 845431 |
| Fax: +39 06 84543700 |
| E-mail: roma@aristea.com |
| Helyszín: www.capriconference.org, XIV CAPRI CONFERENCE "Novel Mechanisms and clinical aspects of cardiovascular disorders" |
The Capri Conference is an established and an international event where join together to develop and deal with the multiple and different discoveries that surround the Cardiovascular world.
This year our invited experts will discuss on various issues: from the management of Thromboembolism to the Atrial fibrillation, from new Antiplatelet Agents to Genetic aspects of Cardiomyopathies and to the latest guide line for the treatment of hypertension, heart and kidney.
The following are some of the Hot Topics:
• RAAS and metabolic syndrome
• Antialdosteronic therapy
• Lipids and cv events in the year 2011 – Residual risk
• New advances in the knowledge of renin
• Prevention/protection of MAU in hypertension
• BP targets in hypertension
• RAS and plaque stability
• RAS and vascular remodeling
• AT2 receptor agonists
• Prevention of CV disease in diabetes
• Prorenin/renin receptors
|
|
|
|
